|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of sales (exclusive of items shown separately below) | |||||
| Selling and marketing expenses | |||||
| Amortization of intangible assets | |||||
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Operating loss | |||||
| Financial income, net | |||||
| Loss before taxes | |||||
| Income tax expenses | |||||
| Comprehensive loss | |||||
| Comprehensive loss attributable to non-controlling interests | |||||
| Comprehensive loss attributable to shareholders of the Company | |||||
| Basic and diluted net loss per share basic | |||||
| Basic and diluted net loss per share diluted | |||||
| Weighted average number of Ordinary Share used in computing basic net loss per share | |||||
| Ordinary Share and prefunded warrants used in computing diluted net loss per share | |||||
Loading...